Suppr超能文献

2,3-二巯基琥珀酸及其衍生物对大鼠体内钋-210的动员与解毒作用

Mobilization and detoxification of polonium-210 in rats by 2,3-dimercaptosuccinic acid and its derivatives.

作者信息

Rencová J, Volf V, Jones M M, Singh P K

机构信息

National Institute of Public Health, Centre of Industrial Hygiene and Occupational Diseases, Praha, Czech Republic.

出版信息

Int J Radiat Biol. 2000 Oct;76(10):1409-15. doi: 10.1080/09553000050151691.

Abstract

PURPOSE

To reduce retention and toxicity of the alpha particle emitter polonium-210 in rats by newly developed chelating agents.

MATERIALS AND METHODS

Repeated subcutaneous chelation was conducted after intravenous injection of 210Po nitrate. For reduction of 210Po retention the treatment with vicinal dithiols meso-and rac-2,3-dimercaptosuccinic acid (DMSA), mono-i-amylmeso-2,3-dimercapto succinate (Mi-ADMS) and mono-N-(i-butyl)-meso-2,3-dimercapto succinamide (Mi-BDMA) were used. For the reduction of toxic effects of 210Po, treatment effectiveness of Mi-BDMA was compared with that of N,N'-di(2-hydroxyethyl)ethylenediamine-N,N'-biscarbodithioate (HOEtTTC, reference compound).

RESULTS

Treatment with meso-DMSA and rac-DMSA altered the main excretion route of 210Po, reduced its contents in the liver but increased its deposition in the kidneys. Treatment with Mi-ADMS or Mi-BDMA increased total excretion of 210Po, mainly via the faeces. Only Mi-BDMA decreased 210Po levels in the kidneys. The effectiveness of all chelators decreased with delay in the start of treatment. In a survival study, the lives of rats treated early with Mi-BDMA or delayed with HOEtTTC were prolonged three-fold when compared with rats receiving a lethal amount of 210Po only.

CONCLUSIONS

Of the vicinal dithiols examined, Mi-BDMA was the best mobilizing chelating agent for 210Po and it reduced 210Po toxicity when the treatment started immediately. However, the detoxification efficacy of the immediate treatment with HOEtTTC, observed in our previous study, was superior to that of the present result with Mi-BDMA.

摘要

目的

通过新开发的螯合剂降低α粒子发射体钋-210在大鼠体内的滞留和毒性。

材料与方法

静脉注射硝酸钋-210后进行重复皮下螯合。为减少钋-210的滞留,使用邻二硫醇内消旋-和外消旋-2,3-二巯基琥珀酸(DMSA)、单异戊基内消旋-2,3-二巯基琥珀酸酯(Mi-ADMS)和单-N-(异丁基)-内消旋-2,3-二巯基琥珀酰胺(Mi-BDMA)进行治疗。为降低钋-210的毒性作用,将Mi-BDMA的治疗效果与N,N'-二(2-羟乙基)乙二胺-N,N'-双碳二硫代酯(HOEtTTC,参考化合物)的治疗效果进行比较。

结果

用内消旋-DMSA和外消旋-DMSA治疗改变了钋-210的主要排泄途径,降低了其在肝脏中的含量,但增加了其在肾脏中的沉积。用Mi-ADMS或Mi-BDMA治疗增加了钋-210的总排泄量,主要通过粪便排出。只有Mi-BDMA降低了肾脏中钋-210的水平。所有螯合剂的有效性随着治疗开始时间的延迟而降低。在一项生存研究中,与仅接受致死剂量钋-210的大鼠相比,早期用Mi-BDMA治疗或延迟用HOEtTTC治疗的大鼠寿命延长了三倍。

结论

在所研究的邻二硫醇中,Mi-BDMA是钋-210的最佳动员螯合剂,且在治疗立即开始时可降低钋-210的毒性。然而,我们先前研究中观察到的立即用HOEtTTC治疗的解毒效果优于目前Mi-BDMA的治疗结果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验